医生对循证指南的依从性是抗凝药相关用药错误发生与严重程度的主要预测因素
本研究为三级医院前瞻性队列研究,纳入116例患者共2166剂抗凝药处方。泊松回归显示女性、桥接、静脉血栓栓塞预防、医生不依从和多重用药是发生率的预测因素;序贯logistic回归显示医生不依从是错误严重程度增加的主要预测因素(OR 24.67)。
要点
- 低分子肝素和普通肝素分别占用药错误总数的61%和34%。
- 医生对循证指南不依从是错误发生率和严重程度的主要预测因素。
核心结论
- 医生对循证指南的依从性是增加用药错误发生率和严重程度的主要预测因素。
- 有必要通过抗凝药物管理计划严格规范抗凝药处方。
研究设计与样本
- 前瞻性队列研究,在三级医院纳入116例患者,共2166剂抗凝药处方。
主要发现
- 超过50%的用药错误为剂量不当(偏高或偏低),见于肝素和亭扎肝素。
- 最高错误严重程度为D类,其次为F类和C类。
临床怎么用
- 临床药师应重点审核抗凝药处方剂量,尤其是肝素类和亭扎肝素。
- 对存在女性、桥接、静脉血栓栓塞预防、多重用药等高危因素的患者加强用药错误监测。
- 推动抗凝药物管理计划以严格规范抗凝药处方,提高医生对循证指南的依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Anticoagulants represent a main source of medication errors (MEs) and complications that have catastrophic implications, posing an obligation on health care providers to assess anticoagulant-related MEs and factors affecting their occurrence. This study investigates the occurrence and severity of prescribing MEs in patients on anticoagulants and explores their potential predictors. METHODS: This study was a prospective cohort study in a tertiary hospital on 116 patients with a total of 2166 anticoagulant doses. RESULTS: Forty-four percent of prescribed anticoagulant doses resulted in MEs with low molecular weight heparin (LMWH) and unfractionated heparin (UFH) causing 61% and 34%, respectively, of the total MEs. More than 50% of all MEs were incorrect doses (high and low) shared between heparin and tinzaparin. The highest severity of error was Category D followed by Category F and Category C. A Poisson regression analysis model revealed that female (incidence rate ratio [IRR] 1.32, 95% confidence interval [CI] 1.13-1.54, P < .001), bridging (IRR 1.52; 95% CI 1.10-2.09; P = .011), venous thromboembolism (VTE) prophylaxis (IRR 7.65; 95% CI 4.88-12.02; P < .001), physician non-adherence (IRR 2.71; 95% CI 2.22-3.29; P < .001), and polypharmacy (IRR 1.68; 95% CI 1.26-2.23; P = .036) were predictors of the higher incidence of MEs. Ordinal logistic regression analysis demonstrated that physician non-adherence (OR 24.67; 95% CI 5.54-207; P < .001) was the main predictor of increased error severity. CONCLUSION: The major predictor in increasing both the incidence and severity of MEs is physician adherence to evidence-based guidelines (EBG). Strict regulations for anticoagulant prescribing through an anticoagulant stewardship program are a necessity.
引用
- El-Bosily HM, Abd El Meguid KR, Sabri NA, et al. Physicians' adherence to evidence-based guidelines as a major predictor of anticoagulant-related medication error incidence and severity. Br J Clin Pharmacol. 2022. PMID: 35293625. doi:10.1111/bcp.15314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。